» Articles » PMID: 39201478

Phytochemicals in Drug Discovery-A Confluence of Tradition and Innovation

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Aug 29
PMID 39201478
Authors
Affiliations
Soon will be listed here.
Abstract

Phytochemicals have a long and successful history in drug discovery. With recent advancements in analytical techniques and methodologies, discovering bioactive leads from natural compounds has become easier. Computational techniques like molecular docking, QSAR modelling and machine learning, and network pharmacology are among the most promising new tools that allow researchers to make predictions concerning natural products' potential targets, thereby guiding experimental validation efforts. Additionally, approaches like LC-MS or LC-NMR speed up compound identification by streamlining analytical processes. Integrating structural and computational biology aids in lead identification, thus providing invaluable information to understand how phytochemicals interact with potential targets in the body. An emerging computational approach is machine learning involving QSAR modelling and deep neural networks that interrelate phytochemical properties with diverse physiological activities such as antimicrobial or anticancer effects.

Citing Articles

Living Coral Displays, Research Laboratories, and Biobanks as Important Reservoirs of Chemodiversity with Potential for Biodiscovery.

Calado R, Leal M, Silva R, Borba M, Ferro A, Almeida M Mar Drugs. 2025; 23(2).

PMID: 39997213 PMC: 11857471. DOI: 10.3390/md23020089.


Anticancer Ribosomally Synthesized and Post-Translationally Modified Peptides from Plants: Structures, Therapeutic Potential, and Future Directions.

Hwang H, Nam Y, Jang C, Kim E, Jang E, Lee Y Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852121 PMC: 11764418. DOI: 10.3390/cimb47010006.


Review of Cathepsin K Inhibitor Development and the Potential Role of Phytochemicals.

Moon D Molecules. 2025; 30(1.

PMID: 39795149 PMC: 11721202. DOI: 10.3390/molecules30010091.

References
1.
Newman D, Cragg G . Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3):770-803. DOI: 10.1021/acs.jnatprod.9b01285. View

2.
Scherlach K, Hertweck C . Mining and unearthing hidden biosynthetic potential. Nat Commun. 2021; 12(1):3864. PMC: 8222398. DOI: 10.1038/s41467-021-24133-5. View

3.
Irurzun-Arana I, McDonald T, Troconiz I, Michor F . Pharmacokinetic Profiles Determine Optimal Combination Treatment Schedules in Computational Models of Drug Resistance. Cancer Res. 2020; 80(16):3372-3382. PMC: 7442591. DOI: 10.1158/0008-5472.CAN-20-0056. View

4.
Auffret M, Drapier S, Verin M . The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future. Drugs R D. 2018; 18(2):91-107. PMC: 5995787. DOI: 10.1007/s40268-018-0230-3. View

5.
Holzmeyer L, Hartig A, Franke K, Brandt W, Muellner-Riehl A, Wessjohann L . Evaluation of plant sources for antiinfective lead compound discovery by correlating phylogenetic, spatial, and bioactivity data. Proc Natl Acad Sci U S A. 2020; 117(22):12444-12451. PMC: 7275773. DOI: 10.1073/pnas.1915277117. View